HeartSciences Inc. HSCS
NASDAQ
| 07/31/2026 | 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -17.00% | -4.30% | 0.37% | -18.52% | -20.28% |
| Total Depreciation and Amortization | 6.09% | 2.58% | 1.50% | 2.39% | 24.41% |
| Total Amortization of Deferred Charges | 211.97% | 335.17% | 187.05% | 585.01% | 282.24% |
| Total Other Non-Cash Items | 321.68% | 237.88% | 295.01% | 95.69% | -22.05% |
| Change in Net Operating Assets | -137.89% | -308.82% | -277.95% | 86.06% | 231.31% |
| Cash from Operations | 7.56% | -0.18% | 0.79% | 4.84% | -9.92% |
| Capital Expenditure | -9.38% | -9.38% | 93.27% | 78.62% | 95.04% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1,085.56% | -51.11% | -22.73% | 58.01% | 52.38% |
| Cash from Investing | -975.75% | -47.84% | 42.84% | 67.92% | 75.17% |
| Total Debt Issued | 62.14% | 62.14% | 62.14% | -100.00% | 453.65% |
| Total Debt Repaid | -61.69% | -162.04% | -162.10% | -187.29% | -30.46% |
| Issuance of Common Stock | -66.35% | -84.94% | -75.89% | -94.25% | -94.83% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -53.83% | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -25.33% | 193.74% | 172.15% | -54.53% | -44.84% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -78.49% | 111.86% | 117.87% | -153.16% | -141.11% |